Marrone Bio Innovations, Inc. Reports 2016 First Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Piper Jaffray Cuts Price Target on Marine Bio (MBII) Following 1Q Report
May 13, 2016 7:58 AM EDTPiper Jaffray maintained an Overweight rating on Marrone Bio Innovations (NASDAQ: MBII), and cut the price target to $1.00 (from $2.00), following the company's 1Q earnings report. Marrone again beat Piper's top line expectations in the March ending quarter as sales growth in the specialty crop market continues to be stronger than expected, more than... More
Marine Bio (MBII) Misses Q1 EPS by 11c
May 12, 2016 4:57 PM EDTMarine Bio (NASDAQ: MBII) reported Q1 EPS of ($0.38), $0.11 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $2.7 million versus the consensus estimate of $3.05 million.
For earnings history and earnings-related data on Marine Bio (MBII) click here.
... More